MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer
暂无分享,去创建一个
Murali M. Yallapu | Nadeem Zafar | Neeraj Chauhan | Meena Jaggi | Subhash C. Chauhan | P. Thompson | N. Chauhan | M. Zaman | S. Khan | Mara C. Ebeling | M. Sikander | Ashley M. Yacoubian | S. Behrman | Nadeem Zafar | Deepak Kumar | M. Jaggi | S. Chauhan | Sheema Khan | Mohd S. Zaman | Mohammed Sikander | Stephen W. Behrman | Deepak Kumar | Paul A. Thompson | M. Yallapu | M. Ebeling
[1] A. Goswami,et al. A Novel MMP-2 Inhibitor 3-azidowithaferin A (3-azidoWA) Abrogates Cancer Cell Invasion and Angiogenesis by Modulating Extracellular Par-4 , 2012, PloS one.
[2] Deepak Kumar,et al. Mucins in ovarian cancer diagnosis and therapy , 2009, Journal of ovarian research.
[3] S. Jain,et al. A cyano analogue of boswellic acid induces crosstalk between p53/PUMA/Bax and telomerase that stages the human papillomavirus type 18 positive HeLa cells to apoptotic death. , 2011, European journal of pharmacology.
[4] R. DePinho,et al. Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.
[5] Michael R Hamblin,et al. CA : A Cancer Journal for Clinicians , 2011 .
[6] Tianyuan Xu,et al. MicroRNA‐145 directly targets the insulin‐like growth factor receptor I in human bladder cancer cells , 2014, FEBS letters.
[7] H. Aburatani,et al. MUC13 Mucin Augments Pancreatic Tumorigenesis , 2011, Molecular Cancer Therapeutics.
[8] H. Aburatani,et al. Expression and functions of transmembrane mucin MUC13 in ovarian cancer. , 2009, Cancer research.
[9] S. Goodman,et al. Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. , 1996, Human pathology.
[10] Q. Yao,et al. Overcoming drug resistance in pancreatic cancer , 2011, Expert opinion on therapeutic targets.
[11] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[12] M. Mimeault,et al. Recent Advances on the Molecular Mechanisms Involved in Pancreatic Cancer Progression and Therapies , 2005, Pancreas.
[13] N. Smorodinsky,et al. The MUC1 oncoprotein as a functional target: Immunotoxin binding to α/β junction mediates cell killing , 2009, International journal of cancer.
[14] S. Khan,et al. Targeting Micrornas in Pancreatic Cancer: Microplayers in the Big Game Pancreatic Cancer and Mirna , 2022 .
[15] Guang-Yuh Chiou,et al. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. , 2013, Cancer research.
[16] Huazong Zeng,et al. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc , 2010, Journal of experimental & clinical cancer research : CR.
[17] Y. Mo,et al. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. , 2010, Cancer research.
[18] C. Bracken,et al. Experimental strategies for microRNA target identification , 2011, Nucleic acids research.
[19] E. Fishman,et al. Recent progress in pancreatic cancer , 2013, CA: a cancer journal for clinicians.
[20] V. Kim,et al. Biogenesis of small RNAs in animals , 2009, Nature Reviews Molecular Cell Biology.
[21] P. Rao,et al. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer. , 2005, Cancer research.
[22] T. Davison,et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma , 2007, Oncogene.
[23] A. Maitra,et al. Pancreatic Carcinogenesis , 2008, Pancreatology.
[24] M. Merino,et al. miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3. , 2014, Endocrine-related cancer.
[25] A. Krogh,et al. MicroRNA-145 Targets YES and STAT1 in Colon Cancer Cells , 2010, PloS one.
[26] Shadi F Othman,et al. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications , 2012, International journal of nanomedicine.
[27] S. Jain,et al. A Novel cyano derivative of 11‐Keto‐β‐Boswellic acid causes apoptotic death by disrupting PI3K/AKT/Hsp‐90 cascade, mitochondrial integrity, and other cell survival signaling events in HL‐60 cells , 2012, Molecular carcinogenesis.
[28] R. Dahiya,et al. MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. , 2011, Cancer research.
[29] Ravibhushan Singh,et al. MUC1: A target molecule for cancer therapy , 2007, Cancer biology & therapy.
[30] Thomas D. Schmittgen,et al. Expression profiling identifies microRNA signature in pancreatic cancer , 2006, International journal of cancer.
[31] D. Kufe,et al. Mucins in cancer: function, prognosis and therapy , 2009, Nature Reviews Cancer.
[32] G. Pan,et al. MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells , 2009, Cell.
[33] Wen Li,et al. miR‐145 suppresses cell invasion in hepatocellular carcinoma cells: miR‐145 targets ADAM17 , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.
[34] Wendy Frankel,et al. MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival , 2008, Journal of Gastrointestinal Surgery.
[35] Qing Xu,et al. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis , 2011, Nucleic acids research.